The Definitive Peptide Research Reference Guide — Compound Review

Home Compounds BPC-157 TB-500 CJC-1295 Ipamorelin GLP-1 GHK-Cu Epithalon NAD+ Comparisons BPC-157 vs TB-500 Sermorelin vs Ipamorelin Semaglutide vs Tirzepatide Guides GHK-Cu Guide GHRH Analogues Ipamorelin Guide Peptide Reconstitution Guide Peptide Injection Sites Guide Peptide Storage Guide Semaglutide Dosage BPC-157 Dosage Research Guides Joint Pain Weight Loss Longevity Vendor Scoreboard All Vendor Comparisons Peptide Price Comparison Vendor Closures & Status How to Read a Peptide COA How to Vet a Peptide Vendor Why Purgo Labs Purgo Labs Review Purgo Labs Discount Code Where to Buy by Compound Legal Status Shop Purgo Labs

Semaglutide for Weight Loss

Semaglutide weight loss research: STEP trial data, GLP-1 mechanisms, and research protocol guide.

How Semaglutide Produces Weight Loss

The STEP (Semaglutide Treatment Effect in People with obesity) program is the most comprehensive obesity trial program for any single agent, enrolling over 4,500 participants across five pivotal trials. Results below are from the primary endpoints at

STEP Trial Weight Loss Results

The titration schedule is not optional — it is essential for GI tolerability. Starting at the 2.4 mg maintenance dose without titration causes severe nausea and vomiting in most patients. The 0.25 mg starting dose is sub-therapeutic and exists purely